1. Welcome to Baptist Board, a friendly forum to discuss the Baptist Faith in a friendly surrounding.

    Your voice is missing! You will need to register to get access to all the features that our community has to offer.

    We hope to see you as a part of our community soon and God Bless!

Merck Pill

Discussion in 'News & Current Events' started by SGO, Oct 11, 2021.

  1. SGO

    SGO Well-Known Member

    Joined:
    Aug 18, 2020
    Messages:
    2,833
    Likes Received:
    533
    Faith:
    Non Baptist Christian
    No, not Mercury or Mercedes.

    Does not say how long the trial was.
    Two days, two weeks, two months, two years, surely not ten years?


    The Epoch Times encourages sharing of their articles. SGO
    Merck Seeks Authorization From US Regulators for Antiviral COVID-19 Treatment

    Merck Seeks Authorization From US Regulators for Antiviral COVID-19 Treatment
    BY ZACHARY STIEBER

    October 11, 2021 Updated: October 11, 2021
    Merck and its partner on Monday announced they filed an emergency use authorization application with the U.S. Food and Drug Administration (FDA) for their oral antiviral medicine for the treatment of COVID-19.

    The pill is meant to combat cases of mild or moderate COVID-19.

    Merck said last week that an interim analysis of its phase 3 trial studying the drug showed it was effective in cutting the risk of hospitalization, a key measure in COVID-19 treatments.

    The antiviral, molnupiravir, cut the risk of hospitalization or death in half for adults who were deemed at risk but not hospitalized, according to a summary Merck released.

    The results were touted by the companies and a number of experts, including former FDA Commissioner Scott Gottlieb.

    “This is a phenomenal result. I mean, this is a profound game changer, to have an oral pill that had this kind of effect, this magnitude of effect in patients who are at high risk who are already symptomatic,” Gottlieb said on CNBC’s “Squawk Box.”

    But full results have not yet been published and other experts have said they’re worried about how the pill attacks the virus.

    Molnupiravir embeds itself in the virus’s genetic material and causes a high number of mutations, ultimately overwhelming it to extinction, a process known as lethal mutagenesis.

    Researchers have said that the method carries risk potential because “the same mutagenic activity that impacts viral replication has the potential for incorporation and mutagenesis of host DNA,” which could contribute to the development of cancer or cause birth defects in an unborn baby. That’s what happened during testing of NHC, the compound molnupiravir creates.

    “There is a concern that this will cause long-term mutation effects, even cancer,” Dr. Shuntai Zhou, a scientist at the Swanstrom Lab at the University of North Carolina, told Barron’s.

    Dr. Michael Carome, director of Public Citizen’s Health Research Group, told The Epoch Times that the concern is theoretical for now and that it’s likely that signaling of rare adverse events would only be possible with long-term trials because premarket trials typically only involve several thousand participants.

    “The FDA is never going to require studies that involve clinical trials that involve tens of thousands or hundreds of thousands of people to increase that signal detection. That’s just the nature of the regulatory review system,” he said. “For rare types of serious events, they’re not going to be detected except in the post-marketing surveillance phase, the post-approval phase, and lots more people are exposed to the drug for longer periods of time than the drug was used in the clinical trials.”

    As an example, regulators approved a class of antibiotics called fluoroquinolones but added warnings on their safety labels years later, after instances of hypoglycemic coma were detected following their use.

    Merck has not responded to requests for comment and said in its latest statement that the clinical trial showed similar adverse events and drug-related adverse events in the group that received its drug and the group that received a placebo.

    “The extraordinary impact of this pandemic demands that we move with unprecedented urgency, and that is what our teams have done by submitting this application for molnupiravir to the FDA within 10 days of receiving the data,” Dr. Robert Davis, Merck’s CEO and president, said in a statement.

    “The submission to the FDA is a critical step towards making molnupiravir available to people who may benefit from an oral antiviral medicine that can be taken at home shortly after diagnosis with COVID-19,” added Wendy Holman, chief executive officer of Ridgeback Biotherapeutics, Merck’s partner.
     
    • Informative Informative x 1
  2. JonC

    JonC Moderator
    Moderator

    Joined:
    Aug 28, 2001
    Messages:
    33,294
    Likes Received:
    3,547
    Faith:
    Baptist
    In 2019 it was in clinical studies as a treatment for influenza. So it is not that new.

    Merch produces another drug (Ivermectin) that is undergoing trials in SC (I'm not sure since studies in India showed the drug ineffective for covid).

    Hopefully it will be an effective treatment.
     
  3. nonaeroterraqueous

    nonaeroterraqueous Active Member

    Joined:
    Aug 6, 2021
    Messages:
    114
    Likes Received:
    44
    Faith:
    Baptist
    Nucleoside analogues, such as this, are a real wrench in the clockworks kind of cure. The theoretical possible side effects are enormous. We'll see.
     
    • Useful Useful x 1
  4. JonC

    JonC Moderator
    Moderator

    Joined:
    Aug 28, 2001
    Messages:
    33,294
    Likes Received:
    3,547
    Faith:
    Baptist
    They approved remdesivir, so I think we will see molnupiravir approved soon (based on the trials) as they work the same (nucleoside analogues).

    I think it will have wide acceptance as many who hesitate about vaccines have little reservations about these types of anti-viral medications.
     
  5. Reynolds

    Reynolds Well-Known Member
    Site Supporter

    Joined:
    Jun 15, 2014
    Messages:
    13,793
    Likes Received:
    2,468
    Faith:
    Baptist
    One Doc I go to thinks Remdisivir is a wonder drug.
    One Doc I go to says it's a death sentence.
     
    • Informative Informative x 1
  6. JonC

    JonC Moderator
    Moderator

    Joined:
    Aug 28, 2001
    Messages:
    33,294
    Likes Received:
    3,547
    Faith:
    Baptist
    I think that's typical. I don't know enough about the drug....but I guess if serious enough it may be worth a try?
     
  7. Wingman68

    Wingman68 Well-Known Member
    Site Supporter

    Joined:
    Dec 22, 2017
    Messages:
    5,077
    Likes Received:
    2,243
    Faith:
    Baptist
    Quit going to the first Doc.
     
    • Agree Agree x 2
Loading...